1/21/2022 | 3004900002 | MEDICINES FOR CONDUCTING A CLINICAL STUDY ACCORDING TO PROTOCOL No. TAK-935-3002, PACKED IN THERMOBOXES WITH WATER-BASED COLD ELEMENTS TO MAINTAIN THE TEMPERATURE DURING TRANSPORTATION FROM 15 TO 25 CELSIUS, THERMOBOXES DO NOT | 2.92 | 7250.65 | Japan | UNKNOWN | FISHER CLINICAL SERVICES LLC |
1/11/2022 | 3004900002 | MEDICINAL FOR CARRYING OUT A CLINICAL STUDY ACCORDING TO PROTOCOL No. TAK-935-3001, PACKED IN A THERMOBOX WITH WATER-BASED COLD ELEMENTS TO MAINTAIN THE TEMPERATURE DURING TRANSPORTATION FROM 15 TO 25 CELSIUS, THERMOBOXES DO NOT | 1.45 | 3530.28 | Japan | Unknown | FISHER CLINICAL SERVICES LLC |
1/11/2022 | 3004900002 | Drugs for retail: KSOSPAT (Gilteritinib) Tablets coated with film shell, 40 mg (blister) 21 x 4 (pack cardboard) - 120 pack., Series 21B0604, suitable to 01.2025, active substance: Gilteritinib Fumarat, producing | 5.66 | 1664942.3 | Japan | MOSCOW RUSSIA | ASTELLAS PHARMA PRODUCTION LLC |
1/12/2022 | 3004900008 | MEDICINE: MIKAMIN OSN. ACTIVE SUBSTANCE: MICAFUNGIN, LYOPHILISATE FOR PREPARATION OF SOLUTION FOR INFUSION 50 MG (BOTTLE) X 1-13000 (CARDBOARD BOX), IN BULK, NOT PACKED FOR RETAIL, WITHOUT INSTRUCTIONS FOR USE, | 22 | 60904.7 | Japan | KHARITONOVO | ASTELLAS PHARMA PRODUCTION LLC |
1/12/2022 | 3004900008 | MEDICINE: MIKAMIN OSN. ACTIVE SUBSTANCE: MICAFUNGIN, LYOPHILIZATE FOR PREPARATION OF SOLUTION FOR INFUSION 100 MG (BOTTLE) X 1-13000 (CARDBOARD BOX), IN BULK, NOT PACKED FOR RETAIL, WITHOUT INSTRUCTIONS FOR USE, | 22 | 119499.4 | Japan | KHARITONOVO | ASTELLAS PHARMA PRODUCTION LLC |